CSA Bulletin
Winter 2009 - Volume 58, Number 1
Editor's Notes
The QT Interval and Droperidol—Do We Have to Use it on the Q.T.?
By Stephen Jackson, M.D.
President's Page
By Michael Champeau M.D.
From the CEO
Transitioning to a New Medicare Carrier
By Barbara Baldwin
Legislative and Practice Affairs
The Political Clout of Managed Care
By William E. Barnaby Esq., CSA Legislative Counsel
Balance Billing and Constitutional Government: A Perfect Storm
By David E. Willett, Esq., CSA Legal Counsel
Francisco J. Silva, Esq., CMA's New V.P. of Legal Affairs and General Counsel
By William Barnaby III, Esq., CSA Legislative Counsel
The ASA Annual Meeting, Orlando
Exciting Times in the World of Enchantment
By Linda J. Mason, M.D.
The Use of Droperidol in Anesthesia Care
By James Moore, M.D.
CON: The Black Box Warning on Droperidol Should Not Be Removed (But Should Be Clarified!)
By Danielle B. Ludwin, M.D., and Steven L. Shafer, M.D.
Annual Meeting of the CMA House of Delegates
By Michele E. Raney, M.D.
2009 CSA Annual Meeting and Clinical Anesthesia Update
California Dreamin'
By Daniel Weintraub
Altered States: LSD and the Anesthesia Laboratory of Henry Knowles Beecher
By George A. Mashour, M.D., Ph.D.
Critical Care CME Program: Module 4
Sepsis Bundles Including Early Goal-Directed Therapy
By Scott Ahlbrand, M.D., and Fred Mihm, M.D.
Arthur E. Guedel Memorial Anesthesia Center
Paluel J. Flagg and the "Art" of Anesthesia
By Merlin D. Larson, M.D.
 |
California Society of Anesthesiologists
951 Mariner's Island Boulevard - Suite 270, San Mateo, CA 94404
